Sandy Spring Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $218K | Hold |
3,146
| – | – | 0.01% | 353 |
|
|
2024
Q4 | $271K | Sell |
3,146
-60
| -2% | -$6.49K | 0.01% | 336 |
|
|
2024
Q3 | $382K | Buy |
3,206
+210
| +7% | +$28K | 0.02% | 311 |
|
|
2024
Q2 | $428K | Buy |
2,996
+54
| +2% | +$7.16K | 0.02% | 291 |
|
|
2024
Q1 | $378K | Buy |
2,942
+292
| +11% | +$34.8K | 0.02% | 304 |
|
|
2023
Q4 | $274K | Hold |
2,650
| – | – | 0.01% | 329 |
|
|
2023
Q3 | $241K | Sell |
2,650
-190
| -7% | -$16.7K | 0.01% | 328 |
|
|
2023
Q2 | $230K | Sell |
2,840
-14
| -0.5% | -$1.14K | 0.01% | 335 |
|
|
2023
Q1 | $227K | Buy |
2,854
+554
| +24% | +$39.3K | 0.01% | 328 |
|
|
2022
Q4 | $156K | Buy |
2,300
+2,000
| +667% | +$117K | 0.01% | 367 |
|
|
2022
Q3 | $15K | Sell |
300
-100
| -25% | -$5.36K | ﹤0.01% | 725 |
|
|
2022
Q2 | $22K | Hold |
400
| – | – | ﹤0.01% | 679 |
|
|
2022
Q1 | $22K | Sell |
400
-200
| -33% | -$10.3K | ﹤0.01% | 692 |
|
|
2021
Q4 | $34K | Hold |
600
| – | – | ﹤0.01% | 657 |
|
|
2021
Q3 | $29K | Hold |
600
| – | – | ﹤0.01% | 680 |
|
|
2021
Q2 | $25K | Sell |
600
-200
| -25% | -$7.75K | ﹤0.01% | 731 |
|
|
2021
Q1 | $27K | Sell |
800
-200
| -20% | -$7.12K | ﹤0.01% | 622 |
|
|
2020
Q4 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 552 |
|
|
2020
Q3 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 516 |
|
|
2020
Q2 | $33K | Sell |
1,000
-78
| -7% | -$2.49K | ﹤0.01% | 522 |
|
|
2020
Q1 | $32K | Sell |
1,078
-322
| -23% | -$9.59K | ﹤0.01% | 506 |
|
|
2019
Q4 | $41K | Hold |
1,400
| – | – | ﹤0.01% | 502 |
|
|
2019
Q3 | $36K | Hold |
1,400
| – | – | ﹤0.01% | 517 |
|
|
2019
Q2 | $36K | Hold |
1,400
| – | – | ﹤0.01% | 516 |
|
|
2019
Q1 | $37K | Sell |
1,400
-1,062
| -43% | -$26.1K | ﹤0.01% | 492 |
|
|
2018
Q4 | $57K | Hold |
2,462
| – | – | 0.01% | 429 |
|
|
2018
Q3 | $58K | Buy |
2,462
+510
| +26% | +$12.4K | ﹤0.01% | 442 |
|
|
2018
Q2 | $45K | Hold |
1,952
| – | – | ﹤0.01% | 480 |
|
|
2018
Q1 | $48K | Hold |
1,952
| – | – | ﹤0.01% | 475 |
|
|
2017
Q4 | $52K | Buy |
+1,952
| New | +$49.6K | ﹤0.01% | 443 |
|
|
2017
Q3 | – | Sell |
-290
| Closed | -$6K | – | 836 |
|
|
2017
Q2 | $6K | Hold |
290
| – | – | ﹤0.01% | 747 |
|
|
2017
Q1 | $5K | Hold |
290
| – | – | ﹤0.01% | 758 |
|
|
2016
Q4 | $5K | Hold |
290
| – | – | ﹤0.01% | 739 |
|
|
2016
Q3 | $6K | Hold |
290
| – | – | ﹤0.01% | 719 |
|
|
2016
Q2 | $8K | Hold |
290
| – | – | ﹤0.01% | 707 |
|
|
2016
Q1 | $8K | Hold |
290
| – | – | ﹤0.01% | 720 |
|
|
2015
Q4 | $8K | Buy |
+290
| New | +$8.03K | ﹤0.01% | 695 |
|
|
2015
Q1 | – | Sell |
-170
| Closed | -$4K | – | 921 |
|
|
2014
Q4 | $4K | Hold |
170
| – | – | ﹤0.01% | 731 |
|
|
2014
Q3 | $4K | Hold |
170
| – | – | ﹤0.01% | 715 |
|
|
2014
Q2 | $4K | Hold |
170
| – | – | ﹤0.01% | 721 |
|
|
2014
Q1 | $4K | Buy |
+170
| New | +$3.62K | ﹤0.01% | 665 |
|
Other funds holding NVO
F
TIM
Sandy Spring Bank's NVO Position: Q1 2025 in Review
Sandy Spring Bank held its Novo Nordisk (NVO) position steady in Q1 2025 at 3,146 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #353.
Sandy Spring Bank first reported a position in NVO in Q1 2014 and has held it in 41 quarters since. The position peaked at $428K in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.
- Sandy Spring Bank held 3,146 shares of Novo Nordisk worth $218K as of Q1 2025.
- Sandy Spring Bank left its Novo Nordisk share count unchanged in Q1 2025.
- Novo Nordisk made up 0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #353 holding.
- Sandy Spring Bank first reported a position in Novo Nordisk in Q1 2014 and has held it in 41 quarters since.
- Sandy Spring Bank's Novo Nordisk position peaked at $428K in Q2 2024.
- 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.